Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
2021 · Nature Communications · 178 citations
https://doi.org/10.1038/s41467-021-26401-w
C
Chao Su
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
1.4K
Citations
15
h-index
16
i10-index
Chao Su is an academic researcher from City University of Hong Kong. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Virus-based gene therapy research. The author has an h-index of 15, co-authored 24 publications.
ORCID: 0000-0002-5824-7968Papers by this author
worksTwo pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
2023 · Cell Reports Medicine · 45 citations
https://doi.org/10.1016/j.xcrm.2023.100918
The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications
2024 · Clinical Epigenetics · 41 citations
https://doi.org/10.1186/s13148-024-01633-x
Equine lentivirus counteracts SAMHD1 restriction by Rev-mediated degradation of SAMHD1 via the BECN1-dependent lysosomal pathway
2020 · Autophagy · 16 citations
https://doi.org/10.1080/15548627.2020.1846301
Enabling the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants including KP.2
2025 · hLife · 9 citations
https://doi.org/10.1016/j.hlife.2024.12.006
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19
2025 · Molecular Biomedicine · 1 citations
https://doi.org/10.1186/s43556-025-00320-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat